HOME>HOME>About ASKA Pharmaceutical Holdings>ASKA Pharmaceutical Holdings in Numbers

ASKA Pharmaceutical Holdings in Numbers

Foundation
創立アイコン

104years

(Founded in 1920)

Female Medicine Research
女性医療研究アイコン

100years

* Over 100 years

Ob/Gyn* field
産婦人科領域アイコン

Top share in Japan

Leading Company

※In-house estimate

Thyroid field
甲状腺領域アイコン

Top share in Japan

95%

Consolidated Sales
連結売上高アイコン

62.8

billion yen

(FY2023)

  • ASKA Pharmaceutical 56.0 billion yen
    (Pharamaceutical business)
  • ASKA Animal Health 6.6 billion yen
    (Animal health business)
  • ASKA Pharma Medical 0.16 billion yen
    (Testing business)
Number of Employees
従業員数アイコン

762

(End of FY2023)

Major business sites
主要事業所アイコン

23

Including 1 international site

Operating profit margin
営業利益率アイコン

10.3

(FY2023)

ROE(Return on Equity)
ROE(自己資本純利益率)アイコン

13.0

(FY2023)

Dividend payout ratio
配当性向アイコン

30

(Benchmark ratio)
*A minimum annual dividend per
share of 30 yen

R&D expenses
研究開発費アイコン

4.7 
billion yen

(FY2023)
*ASKA Pharmaceutical

Promotion of Women's advancement
女性活躍推進アイコン

Ratio of female
employees*1

32.7

Ratio of female management positions*2

12.4

Ratio of female management candidates*1

23.0

*1 End of FY2023 in ASKA Pharmaceutical
*2 As of September 30, 2024 in ASKA Pharmaceutical

Ratio of male employees taking child care leave
男性育児休業取得率アイコン

100.0

(FY2023 in ASKA Pharmaceutical)

Reduction rate of Total CO₂ Emissions
CO₂排出削減率アイコン

49.2

* The rate in FY2023 compared with the rate in FY2013